China Reform Holdings Leads $101M Round In Chinese Precision Medicine Firm 3D Medicines
November 23, 2017 — 11:40 CST
This Data Is Locked!
This area is available only to Subscribers.
China Reform Holdings Co., Ltd. has led a RMB670 million (US$101 million) new funding round in 3D Medicines, a Chinese healthcare firm developing precision medicine... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals